Organogenesis Holdings (ORGO) Gross Profit Growth (1y) (2018 - 2026)
Organogenesis Holdings (ORGO) Gross Profit Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn | 2.43% |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn | -8.36% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -5.56% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | -3.83% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 9.27% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 38.19% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 11.92% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Organogenesis Holdings | 241.26 Mn | 194.42 Mn | 20.08 Mn | -72.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -72.63% |
| Mar 31, 2026 | -81.81% |
| Dec 31, 2025 | 83.77% |
| Sep 30, 2025 | 29.68% |
| Jun 30, 2025 | -27.38% |
| Mar 31, 2025 | -22.53% |
| Dec 31, 2024 | 33.00% |
| Sep 30, 2024 | 6.82% |
| Jun 30, 2024 | 11.03% |
| Mar 31, 2024 | 0.30% |
| Dec 31, 2023 | -18.69% |
| Sep 30, 2023 | -8.76% |
| Jun 30, 2023 | -3.96% |
| Mar 31, 2023 | 12.49% |
| Dec 31, 2022 | -7.20% |
| Sep 30, 2022 | 3.53% |
| Jun 30, 2022 | 1.60% |
| Mar 31, 2022 | -6.51% |
| Dec 31, 2021 | 17.19% |
| Sep 30, 2021 | 12.53% |